Document is current
Any future updates will be listed below
-
Authors
Fisher, J. H. https://orcid.org/0000-0001-8123-923X
Kolb, M.
Algamdi, M.
Morisset, J.
Johannson, K. A.
Shapera, S.
Wilcox, P.
To, T.
Sadatsafavi, M.
Manganas, H.
Khalil, N.
Hambly, N.
Halayko, A. J.
Gershon, A. S.
Fell, C. D.
Cox, G.
Ryerson, C. J.
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim
- License Information
-
More Information
Article History
Received: 2 April 2019
Accepted: 8 November 2019
First Online: 27 November 2019
Ethics approval and consent to participate
: Ethics approval for this study was obtained by the research ethics boards at each participating site. Written consent is required for inclusion in CARE-PF.
: Not applicable.
: KAJ, JM, HM, MK, JHF, GC, CJR, and PW have received grant support for CARE-PF from Boehringer Ingelheim. KAJ has received consultancy fees, speakers honoraria, and travel support from Boehringer Ingelheim and consultancy fees, speakers honoraria, and travel support from Hoffman-La Roche Ltd. CDF has received an unrestricted educational and research Grants from Boehringer Ingelheim. JM has received personal fees from Boehringer Ingelheim and Hoffmann-La Roche ltd. TT has received grants from Ontario Ministry of Health and Long-term Care, Ontario Ministry of the Environment and Climate Change, Canadian Institute for Health Research, Health Canada, and Canadian Respiratory Research Network. MK has received grants from Canadian Pulmonary Fibrosis Foundation, Pulmonary Fibrosis Foundation, Roche Canada, Prometic, Alkermes, and Actelion, personal fees from Boehringer Ingelheim, Roche Canada, GlaxoSmithKline, Gilead, Prometic, and Alkermes and allowance as Chief Editor from the European Respiratory Journal. SS has received personal fees from Astrazeneca, grants, personal fees and other from Boehringer-Ingelheim Canada, grants, personal fees and other from Hoffman La-Roche Canada, other from Medimmune, other from Prometic Canada, other from Sanofi-Aventis, outside the submitted work. NH has received grants and personal fees from Boehringer Ingelheim, grants and personal fees from Roche, grants, personal fees and non-financial support from Actelion, grants, personal fees and non-financial support from Bayer, during the conduct of the study. CJR has received grants from Boehringer Ingelheim, during the conduct of the study; grants and personal fees from Boehringer Ingelheim, grants and personal fees from Hoffmann-La Roche, outside the submitted work.
